Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
CA 2408791 C · Owner: The Feinstein Institutes For Medical Research · Inventors: Tracey, Kevin J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method of inhibiting the release of a proinflammatory cytokine in a cell is disclosed. The method comprises treating the cell with a cholinergic agonist. The method is useful in patients at risk for or suffering from, a condition , mediated by an inflammatory cytokine cascade for example endotoxic shock. The , cholinergic agonist treatment can be effected by stimulation of an efferent vagus nerve fiber, or the entire vagus nerve.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 16, 2001 and granted September 16, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 16, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 16, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.